Evidence map›Paper›PMID 41996190›Full record

ArticleDiabetes2026

Activating Transcription Factor 6α Governs Stress-Adaptive Pancreatic β-Cell Mass Expansion by Coordinating Proliferation and Survival.

Daisuke Otani, Takaaki Murakami, Muhammad Fauzi, Ainur Botagarova, Sho Sekito, Hisato Tatsuoka, Shinsuke Tokumoto, Ryota Usui, Masahito Ogura, Taro Toyoda and 3 more

Abstract read
In one paragraph

Article in Diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daisuke OtaniDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takaaki MurakamiDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID 0000-0003-3844-1138
Muhammad FauziDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ainur BotagarovaDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sho SekitoDepartment of Pathology and Biology of Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hisato TatsuokaResearch and Development Department, General Incorporated Association Kansai Healthcare Science Informatics, Kyoto, Japan.
Shinsuke TokumotoDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ryota UsuiCenter for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.ORCID 0000-0002-4641-0158
Masahito OguraDiabetes Center, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Taro ToyodaDepartment of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Yasuhiro MurakawaDepartment of Pathology and Biology of Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Daisuke YabeDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID 0000-0002-5334-7687
Nobuya InagakiMedical Research Institute, Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan.ORCID 0000-0001-8261-2593

Funding

Foundation of Future Research SupportFujiwara Memorial FoundationJapan Association for Diabetes Education and CareJapan Diabetes FoundationJapan Diabetes SocietyJapan Foundation for Applied EnzymologyJapan IDDM networkJapan Society for the Promotion of ScienceTakeda Science FoundationUehara Memorial Foundation
6 · The paper itself

Abstract

Progressive loss of pancreatic β-cell mass (BCM) is a hallmark of type 2 diabetes, yet strategies to preserve or restore BCM remain elusive due to incomplete understanding of the molecular mechanisms governing β-cell proliferation in adults. The unfolded protein response (UPR) maintains endoplasmic reticulum (ER) proteostasis, but the in vivo role of activating transcription factor 6α (ATF6α), the most recently evolved UPR branch, in β-cell proliferation and survival is unclear. Here, we investigated the role of ATF6α in β-cell adaptation under chronic metabolic and physiological stress. We demonstrated that β-cell-specific ATF6α knockout mice exhibited impaired BCM expansion accompanied by reduced β-cell proliferation and increased apoptosis during high-fat diet feeding and pregnancy, but not under basal conditions. In vitro, ATF6α knockdown suppressed proliferation and enhanced apoptosis in chronically stressed MIN6Akita cells, but not in MIN6 cells, whereas ATF6α overexpression promoted β-cell proliferation. Single-cell transcriptomic analysis further revealed that ATF6α directs proliferative transcriptional states in β-cells under metabolic stress, while its absence diverts cells toward nonproliferative states. Together, these findings establish ATF6α as a coordinating regulator of adaptive β-cell proliferation and survival that supports BCM expansion under sustained stress. ARTICLE HIGHLIGHTS: The role of activating transcription factor 6α (ATF6α) in the stress-adaptive regulation of pancreatic β-cell mass (BCM) in vivo remains incompletely defined. We investigated the role of ATF6α in the regulation of BCM, β-cell proliferation, and survival under sustained stress using in vivo and in vitro models. Loss of ATF6α consistently impaired BCM expansion through reduced β-cell proliferation and increased apoptosis across models. Our findings establish ATF6α as an important regulator of stress-adaptive BCM expansion through coordinating β-cell survival and proliferation under sustained stress.

Indexed as

Activating Transcription Factor 6Cell ProliferationInsulin-Secreting CellsStress, PhysiologicalAnimalsApoptosisCell SurvivalDiet, High-FatFemaleMaleMiceMice, KnockoutPregnancyUnfolded Protein ResponseActivating Transcription Factor 6Atf6 protein, mouse

Identifiers

PMID41996190
PMCPMC13291870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.